Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C.

Vergara M, Bejarano G, Dalmau B, Gil M, Miquel M, Sanchez-Delgado J, Casas M, Puig J, Martinez-Bauer E, Dosal A, Lopez M, Moreno L, Valero O, Bella MR, Calvet X.

Eur J Gastroenterol Hepatol. 2015 Jul;27(7):826-33. doi: 10.1097/MEG.0000000000000346.

PMID:
26043289
2.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6.

PMID:
25567330
3.

Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort.

Manzardo C, Esteve A, Ortega N, Podzamczer D, Murillas J, Segura F, Force L, Tural C, Vilaró J, Masabeu A, Garcia I, Guadarrama M, Ferrer E, Riera M, Navarro G, Clotet B, Gatell JM, Casabona J, Miró JM; PISCIS Investigators.

Clin Microbiol Infect. 2013 Jul;19(7):646-53. doi: 10.1111/j.1469-0691.2012.03991.x. Epub 2012 Sep 12.

4.

The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.

Cain LE, Phillips A, Lodi S, Sabin C, Bansi L, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, de Wolf F, Bucher HC, Elzi L, Touloumi G, Vourli G, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Abgrall S, Costagliola D, Hernán MA; HIV-CAUSAL Collaboration.

AIDS. 2012 Aug 24;26(13):1691-705.

5.

Effectiveness of rituximab in severe Wegener's granulomatosis: report of two cases and review of the literature.

Oristrell J, Bejarano G, Jordana R, Monteagudo M, Marí B, Casanovas A, Tolosa C.

Open Respir Med J. 2009 Jun 25;3:94-9. doi: 10.2174/1874306400903010094.

6.

Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.

Bejarano G, Vergara M, Dalmau B, Puig J, Bella MR, Suárez D, Calvet X.

Rev Esp Enferm Dig. 2009 May;101(5):325-35. English, Spanish.

7.

[Infectious osteitis pubis].

Gabarró L, Font B, Sala M, Serrate G, Bejarano G, Segura F.

Enferm Infecc Microbiol Clin. 2008 Jun-Jul;26(6):345-7. Spanish.

PMID:
18588817
8.

Killing of Coccidioides immitis by human peripheral blood mononuclear cells.

Ampel NM, Bejarano GC, Galgiani JN.

Infect Immun. 1992 Oct;60(10):4200-4.

10.
11.

Serum and red cell enzyme variants in an Amerindian tribe: the Sirionos (Eastern Bolivia).

Vergnes H, Quilici JC, Gherardi M, Bejarano G.

Hum Hered. 1976;26(4):252-62.

PMID:
976993
12.

A clinico-serologic study of pinta in the Alto Beni region, Bolivia.

Edmundson WF, Demis DJ, Bejarano G.

Dermatol Int. 1967 Apr-Jun;6(2):64-76. No abstract available.

PMID:
4869740
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk